Domestic Manufacturing Of A Modified Version Of The Anti-Influenza Drug TamifluĀ® Dry Syrup 3%
Mon, 24 Jul 2006 06:00 AM EST
... Japan - Chugai Pharmaceutical Co., Ltd. ("Chugai") [Head Office: Chuo-ku, Tokyo. President: Osamu Nagayama] announced today that the company has decided to manufacture a modified version of "TamifluĀ® Dry Syrup 3%" in Japan. TamifluĀ® Dry Syrup is a dry syrup formulation of the anti-influenza drug "oseltamivir" that Chugai imports from F. Hoffmann-La Roche Ltd. [click link for full article] ...
Related Topics
- Influenza
- Domestic Violence
- Dry Cleaning
- Dry Mouth
- Violence
- Guaifenesin and Hydrocodone Oral Syrup
- Drug and Medical Device Safety
- Wrinkles
- Carbinoxamine, Pseudoephedrine and Dextromethorphan Oral Syrup
- Terrorism
- Abuse
- Theophylline Oral Solution, Syrup, or Suspension
- Zidovudine Oral Syrup
- Brompheniramine and Pseudoephedrine Oral Solution
- Influenza and Colds
- Cough
- Virus
- Drug Safety
- Anxiety
- Prescription Drugs

Not Signed In -

